Viatris VTRS
NASDAQ VTRS
$16.14 -0.11 (-0.68%)
At close: Aug 20, 2026 · 11:52 AM UTC

Viatris (VTRS) EBITDA Margin (2019 - 2026)

Viatris (VTRS) posted quarterly EBITDA Margin of 2.27% for Q1 2026, up 8630.0% year-over-year from 0.03% in Q1 2025, and up 55.92% quarter-over-quarter from 5.15% in Q4 2025.

Viatris (VTRS) EBITDA Margin (2019 - 2026) Analysis & Trends

Viatris' EBITDA Margin history runs 8 years deep, the most recent figure standing at 2.27% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 8630.0% year-over-year to 2.27%; the TTM figure through Mar 2026 stood at 0.96% (up 2251.0% YoY), while the FY2025 annual figure was 18.62%, down 1869.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 2.27%, up from 5.15% in the prior quarter.
  • The five-year high for EBITDA Margin was 16.93% in Q1 2022, with the low at 88.57% in Q1 2025.
  • The 5-year median for EBITDA Margin is 5.57% (2024), against an average of 1.53%.
  • The sharpest annual moves came in 2025 and 2026: EBITDA Margin plunged 9413 bps in 2025, then surged 8630 bps in 2026.
  • Viatris' EBITDA Margin stood at 5.15% in 2022, then sank by 132 bps to 11.96% in 2023, then jumped by 57 bps to 5.16% in 2024, then rose by 0 bps to 5.15% in 2025, then soared by 56 bps to 2.27% in 2026.
  • Business Quant data shows VTRS's EBITDA Margin at 2.27% in Q1 2026, 5.15% in Q4 2025, and 4.76% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn -5.58%
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 33.91%
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn 16.51%
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn 42.23%
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn 0.17%
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn 15.80%
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn 18.13%
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn 3.70%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.17%
Mar 31, 2026 -2.27%
Dec 31, 2025 -5.15%
Sep 30, 2025 4.76%
Jun 30, 2025 6.53%
Mar 31, 2025 -88.57%
Dec 31, 2024 -5.16%
Sep 30, 2024 6.02%
Jun 30, 2024 -6.34%
Mar 31, 2024 5.57%
Dec 31, 2023 -11.96%
Sep 30, 2023 11.48%
Jun 30, 2023 9.42%
Mar 31, 2023 10.72%
Dec 31, 2022 -5.15%
Sep 30, 2022 13.77%
Jun 30, 2022 13.37%
Mar 31, 2022 16.93%
Dec 31, 2021 -1.76%
Sep 30, 2021 7.91%